These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26467509)

  • 1. Biomarkers in the Management of Difficult Asthma.
    Schleich F; Demarche S; Louis R
    Curr Top Med Chem; 2016; 16(14):1561-73. PubMed ID: 26467509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.
    Porsbjerg C; Lund TK; Pedersen L; Backer V
    J Asthma; 2009 Aug; 46(6):606-12. PubMed ID: 19657904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes.
    Ntontsi P; Loukides S; Bakakos P; Kostikas K; Papatheodorou G; Papathanassiou E; Hillas G; Koulouris N; Papiris S; Papaioannou AI
    Allergy; 2017 Nov; 72(11):1761-1767. PubMed ID: 28407269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma?
    Tsujino I; Nishimura M; Kamachi A; Makita H; Munakata M; Miyamoto K; Kawakami Y
    Respiration; 2000; 67(6):645-51. PubMed ID: 11124647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?
    Demarche S; Schleich F; Henket M; Paulus V; Van Hees T; Louis R
    BMC Pulm Med; 2016 Apr; 16():46. PubMed ID: 27044366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma.
    Feng Y; Liu X; Wang Y; Du R; Mao H
    Chin Med J (Engl); 2023 Jul; 136(13):1513-1522. PubMed ID: 37185590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Asthma in clinical practice: from inflammatory phenotypes to personalized treatment].
    Schleich F; Graff S; Bougard N; Frix AN; Peerboom S; Demarche S; Guissard F; Paulus V; Henket M; Calmès D; Moermans C; Louis R
    Rev Med Liege; 2022 May; 77(5-6):289-294. PubMed ID: 35657185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
    Baines KJ; Simpson JL; Wood LG; Scott RJ; Fibbens NL; Powell H; Cowan DC; Taylor DR; Cowan JO; Gibson PG
    J Allergy Clin Immunol; 2014 Apr; 133(4):997-1007. PubMed ID: 24582314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of exhaled hydrogen sulfide and airway inflammatory phenotype in patients with chronic persistent asthma.
    Zhang J; Wang X; Chen Y; Yao W
    Respirology; 2014 Nov; 19(8):1165-9. PubMed ID: 25168466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Airway inflammation and small airway wall remodeling in neutrophilic asthma].
    Gai XY; Chang C; Wang J; Liang Y; Li MJ; Sun YC; He B; Yao WZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):645-650. PubMed ID: 30122765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the diagnosis of eosinophilic asthma.
    Coumou H; Bel EH
    Expert Rev Respir Med; 2016 Oct; 10(10):1093-103. PubMed ID: 27624868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
    Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
    Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
    Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
    J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway inflammation phenotype prediction in asthma patients using lung sound analysis with fractional exhaled nitric oxide.
    Shimoda T; Obase Y; Nagasaka Y; Nakano H; Kishikawa R; Iwanaga T
    Allergol Int; 2017 Oct; 66(4):581-585. PubMed ID: 28318886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma.
    Nagasaki T; Matsumoto H; Izuhara K;
    Allergol Int; 2017 Jul; 66(3):404-410. PubMed ID: 28256388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes.
    Gao W; Han GJ; Zhu YJ; Mao D; Hu H
    Biomark Med; 2020 Feb; 14(3):211-222. PubMed ID: 31910648
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of steroid therapy on inflammatory cell subtypes in asthma.
    Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
    Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of airway inflammation phenotype in patients with bronchial asthma and its correlation with control level].
    Li HW; Lin JT; Nong Y; Ren ZC; Han QQ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1692-1697. PubMed ID: 31216813
    [No Abstract]   [Full Text] [Related]  

  • 19. Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
    Barbaro MP; Spanevello A; Palladino GP; Salerno FG; Lacedonia D; Carpagnano GE
    Eur J Intern Med; 2014 Jan; 25(1):92-6. PubMed ID: 24070522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
    Demarche SF; Schleich FN; Paulus VA; Henket MA; Van Hees TJ; Louis RE
    Respir Res; 2017 Jul; 18(1):133. PubMed ID: 28673351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.